Could a common cholesterol pill fight cervical cancer? new trial investigates
NCT ID NCT06191133
First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 2 times
Summary
This early-phase study is testing whether fenofibrate, a drug normally used to lower cholesterol, can help treat HPV-related cervical cancer and high-grade cervical dysplasia. Researchers will give the drug to 24 adults before their planned surgery and then examine tissue samples to see if it restores normal p53 function and changes tumor metabolism. The goal is to understand if fenofibrate can slow or stop tumor growth, not to cure the disease at this stage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL INTRAEPITHELIAL NEOPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
RECRUITINGCleveland, Ohio, 44106, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a portable heat device match cryotherapy for cervical precancer?
- Could a Light-Activated cream replace surgery for cervical precancer?
- Cervical surgery may alter blood flow to the uterus
- Enzyme-HPV link in cervical disease explored
- Anesthesia choice may change surgical outcomes in cervical treatment
- Ice pack on the belly may ease pain after keyhole hysterectomy